Safety of off-label erythropoiesis-stimulating agents for critically ill patients
Editorial Group: Cochrane Anaesthesia Group
Published Online: 12 FEB 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Safety of off-label erythropoiesis-stimulating agents for critically ill patients (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010969. DOI: 10.1002/14651858.CD010969.
- Publication Status: New
- Published Online: 12 FEB 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
With a focus on safety, we aim to assess the effects of ESAs (ESAs alone or in combination) compared with placebo, no treatment or a different active treatment regimen when administered off-label to critically ill patients. We will further describe and explore heterogeneity and will assess the influence of bias on the robustness of our effect estimates.